Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-06-013254
Filing Date
2006-03-31
Accepted
2006-03-31 17:22:50
Documents
8
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 v038903_10-k.htm 10-K 3099881
2 GRAPHIC chart.jpg GRAPHIC 21198
3 v038903_ex-14.htm EX-14 22438
4 v038903_ex21-1.htm EX-21.1 8582
5 v038903_ex31-1.htm EX-31.1 20364
6 v038903_ex31-2.htm EX-31.2 21033
7 v038903_ex32-1.htm EX-32.1 6416
8 v038903_ex32-2.htm EX-32.2 6303
  Complete submission text file 0001144204-06-013254.txt   3215856
Mailing Address 825 THIRD AVENUE 40TH FLOOR NEW YORK NY 10022
Business Address 825 THIRD AVENUE 40TH FLOOR NEW YORK NY 10022 212-838-1111
INYX INC (Filer) CIK: 0001114241 (see all company filings)

EIN.: 752870720 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-83152 | Film No.: 06730104
SIC: 2834 Pharmaceutical Preparations